Study to Assess Safety, Tolerability and Reactogenicity of Vaccine "UniFluVec" After Two Intranasal Administrations in Healthy Volunteers
Clinical trial NCT04650971 · COMPLETED
Trial details
- NCT number
- NCT04650971
- Sponsor
- Pharmenterprises Biotech LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-29
- Primary completion
- 2020-03-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.